Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$5,334,768
+$767,478 QoQ
Shares Held
21,200
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,269
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $45,805,043 across 9 Drug Manufacturers - General names. ABBV ranks #5 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,750 | $10,495,013 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,500 | $7,390,890 | |
| 3 | JNJ |
Johnson & Johnson
|
28,200 | $7,161,954 | |
| 4 | AMGN |
Amgen Inc
|
16,400 | $5,938,768 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
21,200 | $5,334,768 | |
| 6 | PFE |
Pfizer Inc
|
166,450 | $4,008,116 | |
| 7 | MRK |
Merck & Co., Inc.
|
30,000 | $3,855,000 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,000 | $1,210,020 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,334,768 | 21,200 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,567,290 | 21,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $5,255,270 | 23,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,239,119 | 35,584 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $7,254,772 | 39,084 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,352,320 | 16,000 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $2,398,950 | 13,500 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $2,330,264 | 11,800 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $2,315,520 | 13,500 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $2,458,350 | 13,500 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $2,092,095 | 13,500 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $2,012,310 | 13,500 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $3,098,790 | 23,000 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $3,107,715 | 19,500 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $4,085,985 | 25,283 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $3,930,071 | 29,283 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $5,204,529 | 33,981 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $4,049,669 | 24,981 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $4,113,587 | 30,381 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $5,119,186 | 47,457 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $3,595,581 | 31,921 | Shares | Sole | 2025-03-13 | |
| 2021-03-31 | $2,382,787 | 22,018 | Shares | Sole | 2025-03-13 | |
| 2020-12-31 | $2,359,228 | 22,018 | Shares | Sole | 2025-03-13 | |
| 2020-09-30 | $1,928,556 | 22,018 | Shares | Sole | 2025-03-13 | |
| 2020-06-30 | $2,161,727 | 22,018 | Shares | Sole | 2025-03-13 | |
| 2020-03-31 | $1,354,048 | 17,772 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||